{"id":"NCT01908842","sponsor":"Orexo AB","briefTitle":"Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults","officialTitle":"Induction, STabilization, Adherence, and Retention Trial (ISTART) - A Randomized, Non-inferiority, Multicenter Study to Assess Early Treatment Efficacy of OX219 Versus SUBOXONE Film and to Explore Switching Between Treatments","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2013-07-26","resultsPosted":"2015-05-22","lastUpdate":"2017-05-10"},"enrollment":759,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Opioid Dependence, on Agonist Therapy"],"interventions":[{"type":"DRUG","name":"BNX sublingual tablets","otherNames":["OX219","Zubsolv"]},{"type":"DRUG","name":"BNX sublingual film","otherNames":["Suboxone film"]},{"type":"DRUG","name":"Buprenorphine","otherNames":["Generic buprenorphine"]}],"arms":[{"label":"Buprenorphine; then OL BNX film, then BNX tablets","type":"ACTIVE_COMPARATOR"},{"label":"BNX tablets, then OL BNX tablets, then BNX film","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to assess retention in treatment after induction with buprenorphine/naloxone (BNX) sublingual tablets compared with generic buprenorphine and after stabilization with BNX sublingual tablets compared with BNX film. Secondary objectives included assessment of treatment effects on opioid withdrawal symptoms, opioid cravings, and safety.","primaryOutcome":{"measure":"Primary Endpoints of Retention in Treatment at Days 3 and 15","timeFrame":"Day 3 and Day 15","effectByArm":[{"arm":"BNX Tablets, Then OL BNX Tablets, Then BNX Film","deltaMin":309,"sd":null},{"arm":"Buprenorphine, Then OL BNX Film, Then BNX Tablets","deltaMin":302,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":36,"countries":["United States"]},"refs":{"pmids":["26412801"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":383},"commonTop":["Headache","Vomiting","Nausea","Dry mouth","Insomnia"]}}